Annoroad, a Beijing Gene Services Company, Raises $100 Million in C Round
publication date: Nov 2, 2017
Annoroad, a Beijing genetics services company, raised $100 million in a Series C financing, led by SAIF Partners and joined by SBCVC, Shenzhen GTJA Investment Group and Ping An Ventures. Founded in 2012, Annoroad makes non-invasive prenatal diagnostic tests and also assists life science companies in their genetic research. The company has formed partnerships with Illumina for sequencing, Intel for precision medicine and AliCloud, for a cloud-based bioinformatics program called Solar Genomics. More details....
Stock Symbols: (NSDQ: ILMN) (NSDQ: INTC) (NYSE: BABA)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.